# Safety of Sofosbuvir ,Daclatasvir in HCV Patients and RAVS in Resistent and Relapsed Cases

> **NCT03572140** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 297 (estimated)

## Conditions studied

- HCV

## Interventions

- **DIAGNOSTIC_TEST:** RAVS In relapsed and resistent cases

## Key facts

- **NCT ID:** NCT03572140
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-01
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-08-01
- **Target enrollment:** 297 (ESTIMATED)
- **Last updated:** 2018-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03572140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03572140, "Safety of Sofosbuvir ,Daclatasvir in HCV Patients and RAVS in Resistent and Relapsed Cases". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT03572140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*